Paul Lingor
Department of Neurology
University Medicine Göttingen
Robert-Koch-Strasse 40
37075
Germany
Name/email consistency: high
- Axonal degeneration as a therapeutic target in the CNS. Lingor, P., Koch, J.C., Tönges, L., Bähr, M. Cell Tissue Res. (2012)
- ROCK inhibition and CNTF interact on intrinsic signalling pathways and differentially regulate survival and regeneration in retinal ganglion cells. Lingor, P., Tönges, L., Pieper, N., Bermel, C., Barski, E., Planchamp, V., Bähr, M. Brain (2008)
- Targeting neurological disease with RNAi. Lingor, P., Bähr, M. Mol. Biosyst (2007)
- Functional applications of novel Semliki Forest virus vectors are limited by vector toxicity in cultures of primary neurons in vitro and in the substantia nigra in vivo. Lingor, P., Schöll, U., Bähr, M., Kügler, S. Exp. Brain. Res (2005)
- Down-regulation of apoptosis mediators by RNAi inhibits axotomy-induced retinal ganglion cell death in vivo. Lingor, P., Koeberle, P., Kügler, S., Bähr, M. Brain (2005)
- Transfection of "naked" siRNA results in endosomal uptake and metabolic impairment in cultured neurons. Lingor, P., Michel, U., Schöll, U., Bähr, M., Kügler, S. Biochem. Biophys. Res. Commun. (2004)
- The long processes of short interfering RNAs--RNA interference and its implications in neuronal cells. Lingor, P., Michel, U., Bähr, M. Neurodegener. Dis (2004)
- Paraneoplastic polymyositis in recurring adrenal gland carcinoma. Lingor, P., von Boetticher, D., Bähr, M., Fassbender, K. Lancet. Neurol (2003)
